Browse treatments

…edication costs (€−557, –29.7%) compared with the year prior to biologic therapy were observed. Welfare transfers and foregone income were unaff…

…in patients with difficult-to-treat asthma being considered for biologic therapy.Methods The first 150 patients with difficult-to-treat asthma r…

…d medications, including ICS, in patients with severe asthma on biologic therapy.Methods A targeted literature review (TLR) evaluated evidence o…

…halers (TAI) and dispensing data is essential before initiating biologic therapy, as adherence ensures treatment effectiveness.Aim and Objective…

… emissions (11.5 vs 1.0, p<0,001) 12 months after initiation of biologic therapy when compared 12 months pre-biologic. There was a numerical dif…

…with immunotherapy and may be refractory to corticosteroids and biologic therapy. Evidence guiding management beyond anti-tumour necrosis factor…

…on to adult services. Sixty-seven children (53%) were receiving biologic therapy at the time of the audit, including infliximab in 47, adalimuma…

…s. During follow-up, 19.6% (n=10) of patients were treated with biologic therapy.Conclusions Assessment for sexually transmitted causes of proct…

…trol in patients with moderate-to-severe psoriasis treated with biologics and to analyse discrepancies between PROs and the Psoriasis Are…

…MI 31.5±6.9, 85.3% presented type 2 asthma. 44.12% had received biologic therapy. The main outcomes were: Pre-Treatment Post-Treatment P-value F…

…exacerbations, healthcare burden, and impaired quality of life. Biologic therapies have changed the management of these patients, but real-world p…

…eosinophilic oesophagitis and use of antibiotics in early life, acid suppressant therapy, caesarean delivery, preterm birth, and exclusive formula feedi…